Eksentricity’s Post

US Markets Dip, FDA Boosts Tolebrutinib, and EVgo Secures $1.25B for Charging Growth - US stock markets declined 0.5% on December 12th. - Costco’s Q1 revenue exceeded $62 billion. - Pennsylvania considers a $700 million Bitcoin reserve. - FDA granted tolebrutinib Breakthrough Therapy designation. - EVgo received a $1.25 billion loan for charging stations. Read today's full summary https://lnkd.in/dM7Q7bp5 #Markets #Economy #Innovation #Investing #AI #Sustainability #FinTech #Entrepreneurship #Technology #AlternativeEnergy #Bitcoin #FDA

US Markets Dip, FDA Boosts Tolebrutinib, and EVgo Secures $1.25B for Charging Growth

US Markets Dip, FDA Boosts Tolebrutinib, and EVgo Secures $1.25B for Charging Growth

http://eksentricity.ai

To view or add a comment, sign in

Explore topics